GGrantIndex
Sort

1,049,261 grants matching t cell

Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences

$2,361,915
Sharon Kujawa · Massachusetts Eye And Ear Infirmary · P50 · FY2021 · DC

Center for the Study of Immune Mechanisms of Flavivirus Control

$2,361,857
Michael J Gale · University Of Washington · U19 · FY2015 · AI

Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response

$2,361,658
Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2024 · CA

Signaling Mechanisms Underlying Neuroleptic Drug Actions

$2,361,458
Paul Greengard · Rockefeller University · P50 · FY2006 · MH

Health and Retirement Study: Years 29-34

$2,361,446
David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2020 · AG

Health and Retirement Study: Years 29-34

$2,361,446
David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2021 · AG

Health and Retirement Study: Years 29-34

$2,361,446
David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2022 · AG

Health and Retirement Study: Years 29-34

$2,361,446
David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2023 · AG

Resolving epigenetic instability during pluripotent state transitions: a roadmap for exploiting the biomedical potential of dynamic human stem cell states

$2,361,375
Thorold Theunissen · Washington University · DP2 · FY2019 · GM

Immunologic and Imaging studies with TNF Therapy in Prodromal Synucleinopathies

$2,361,361
Jesse Cedarbaum · Yale University · R01 · FY2025 · AG

NEW TOOLS FOR EXPLORING THE DYNAMIC INTERACTOME

$2,361,291
Michael P Rout · Rockefeller University · U54 · FY2009 · RR

The Psychophysiology of Fear and Anxiety

$2,361,159
Christian Grillon · National Institute Of Mental Health · ZIA · FY2017 · MH

Development of new therapies for neuroblastoma

$2,361,109
Hong Ha Rosa Nguyen · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

CP-CTNet Coordinating Center

$2,361,057
Jens Eickhoff · University Of Wisconsin-Madison · U24 · FY2023 · CA

Harnessing optogenetics to diagnose and therapeutically rewire cancer cell signaling

$2,361,042
Jared E Toettcher · Princeton University · DP2 · FY2016 · EB

Center for Pediatric Research

$2,361,000
David A Pearce · Sanford Research/Usd · P20 · FY2013 · GM

Life Course Cancer Epidemiology Cohort in Women

$2,361,000
Walter C. Willett · Harvard School Of Public Health · U01 · FY2022 · CA

Chronic DTH and IFN-gamma in Human Graft Arteriosclerosis

$2,360,957
Jordan S Pober · Yale University · P01 · FY2010 · HL

Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease

$2,360,820
Towfique Raj · Icahn School Of Medicine At Mount Sinai · RF1 · FY2021 · AG

COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION

$2,360,737
Clint Dart · Health Decisions, Inc. · N01 · FY2017 · HD

SPORE in Breast Cancer

$2,360,642
Carlos L Arteaga · Vanderbilt University · P50 · FY2007 · CA

Functional Imaging of The Brain

$2,360,641
Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

High Performance Biomedical Computing And Informatics

$2,360,573
Calvin A Johnson · Computer Research And Technology · Z01 · FY2007 · CT

Diverse Roles of Reactive Oxygen Species and Inflammation in Vascular Disease

$2,360,539
Kathy K Griendling · Emory University · P01 · FY2009 · HL

RESEARCH-PGR: SECRETome Project: Systematic Evaluation of CellulaR ExporT from plant cells

$2,360,435
Bing Yang · Iowa State University · · FY2017 · BIO